The FDA is conducting a comprehensive review of testosterone therapy applications in menopausal women, responding to growing clinical interest and patient demand. The agency's consultation process has garnered substantial public participation, with testimonials highlighting significant improvements in sexual function, physical vitality, and overall well-being. This regulatory examination reflects broader discussions about hormone replacement options and their efficacy in addressing menopause-related symptoms, though medical professionals continue evaluating safety profiles and long-term health implications.

Summary auto-generated by AI from the original publisher's content. Editorial standards.